Development, And Translation Forum On Drug Discovery
bibliografia
-
Toward A Framework To Improve Diversity And Inclusion In Clinical TrialseBookNATIONAL ACADEMIES PRESS03-20250,00€
-
Optimizing Public-Private Partnerships For Clinical Cancer ResearcheBookNATIONAL ACADEMIES PRESS10-20240,00€
-
Adult Attention-Deficit/Hyperactivity DisordereBookNATIONAL ACADEMIES PRESS08-20240,00€
-
Addressing Treatment Resistance In The Development Of Cancer Immune Modulator TherapeuticseBookNATIONAL ACADEMIES PRESS07-20240,00€
-
Preparing The Future Workforce In Drug Research And DevelopmenteBookNATIONAL ACADEMIES PRESS07-20240,00€
-
Defining And Evaluating In-Home Drug Disposal Systems For Opioid AnalgesicseBookNATIONAL ACADEMIES PRESS04-20240,00€
-
Accelerating The Development And Uptake Of Rapid Diagnostics To Address Antibiotic ResistanceeBookNATIONAL ACADEMIES PRESS07-20230,00€
-
Inclusion Of Pregnant And Lactating Persons In Clinical TrialseBookNATIONAL ACADEMIES PRESS03-20230,00€
-
Envisioning A Transformed Clinical Trials Enterprise For 2030eBookNATIONAL ACADEMIES PRESS04-20220,00€
-
Drug Research And Development For Adults Across The Older Age SpaneBookNATIONAL ACADEMIES PRESS12-20210,00€
-
Innovation In Drug Research And Development For Prevalent Chronic DiseaseseBookNATIONAL ACADEMIES PRESS12-20210,00€
-
Role Of Digital Health Technologies In Drug DevelopmenteBookNATIONAL ACADEMIES PRESS10-20200,00€
-
Reflections On Sharing Clinical Trial DataeBookNATIONAL ACADEMIES PRESS10-20200,00€
-
Enhancing Scientific Reproducibility In Biomedical Research Through Transparent ReportingeBookNATIONAL ACADEMIES PRESS04-20200,00€
-
Virtual Clinical TrialseBookNATIONAL ACADEMIES PRESS10-20190,00€
-
Examining The Impact Of Real-World Evidence On Medical Product DevelopmenteBookNATIONAL ACADEMIES PRESS04-20190,00€
-
Examining The Impact Of Real-World Evidence On Medical Product DevelopmenteBookNATIONAL ACADEMIES PRESS04-20190,00€
-
Enabling Precision MedicineeBookNATIONAL ACADEMIES PRESS10-20170,00€
-
Enabling Precision MedicineeBookNATIONAL ACADEMIES PRESS10-20170,00€
-
Real-World Evidence Generation And Evaluation Of TherapeuticseBookNATIONAL ACADEMIES PRESS07-20170,00€
-
Real-World Evidence Generation And Evaluation Of TherapeuticseBookNATIONAL ACADEMIES PRESS07-20170,00€
-
Deriving Drug Discovery Value From Large-Scale Genetic BioresourceseBookNATIONAL ACADEMIES PRESS11-20160,00€
-
Deriving Drug Discovery Value From Large-Scale Genetic BioresourceseBookNATIONAL ACADEMIES PRESS11-20160,00€
-
Advancing The Discipline Of Regulatory Science For Medical Product DevelopmenteBookNATIONAL ACADEMIES PRESS07-20160,00€
-
Advancing The Discipline Of Regulatory Science For Medical Product DevelopmenteBookNATIONAL ACADEMIES PRESS07-20160,00€
-
Rapid Medical Countermeasure Response To Infectious DiseaseseBookNATIONAL ACADEMIES PRESS02-20160,00€
-
Rapid Medical Countermeasure Response To Infectious DiseaseseBookNATIONAL ACADEMIES PRESS02-20160,00€
-
Financial Incentives To Encourage Development Of Therapies That Address Unmet Medical Needs For Nervous System DisorderseBookNATIONAL ACADEMIES PRESS10-20150,00€
-
Financial Incentives To Encourage Development Of Therapies That Address Unmet Medical Needs For Nervous System DisorderseBookNATIONAL ACADEMIES PRESS10-20150,00€
-
Characterizing And Communicating Uncertainty In The Assessment Of Benefits And Risks Of Pharmaceutical ProductseBookNATIONAL ACADEMIES PRESS12-20140,00€
-
Characterizing And Communicating Uncertainty In The Assessment Of Benefits And Risks Of Pharmaceutical ProductseBookNATIONAL ACADEMIES PRESS12-20140,00€
-
Global Crisis Of Drug-Resistant Tuberculosis And Leadership Of China And The BricseBookNATIONAL ACADEMIES PRESS02-20140,00€
-
Global Crisis Of Drug-Resistant Tuberculosis And Leadership Of China And The BricseBookNATIONAL ACADEMIES PRESS02-20140,00€
-
Large Simple Trials And Knowledge Generation In A Learning Health SystemeBookNATIONAL ACADEMIES PRESS12-20130,00€
-
Large Simple Trials And Knowledge Generation In A Learning Health SystemeBookNATIONAL ACADEMIES PRESS12-20130,00€
-
International Regulatory Harmonization Amid Globalization Of Drug DevelopmenteBookNATIONAL ACADEMIES PRESS10-20130,00€
-
International Regulatory Harmonization Amid Globalization Of Drug DevelopmenteBookNATIONAL ACADEMIES PRESS10-20130,00€
-
Sharing Clinical Research DataeBookNATIONAL ACADEMIES PRESS05-20130,00€
-
Sharing Clinical Research DataeBookNATIONAL ACADEMIES PRESS05-20130,00€
-
Developing And Strengthening The Global Supply Chain For Second-Line Drugs For Multidrug-Resistant TuberculosiseBookNATIONAL ACADEMIES PRESS02-20130,00€
-
Developing And Strengthening The Global Supply Chain For Second-Line Drugs For Multidrug-Resistant TuberculosiseBookNATIONAL ACADEMIES PRESS02-20130,00€
-
Accelerating The Development Of New Drugs And DiagnosticseBookNATIONAL ACADEMIES PRESS10-20120,00€
-
Accelerating The Development Of New Drugs And DiagnosticseBookNATIONAL ACADEMIES PRESS10-20120,00€
-
Envisioning A Transformed Clinical Trials Enterprise In The United StateseBookNATIONAL ACADEMIES PRESS09-20120,00€
-
Envisioning A Transformed Clinical Trials Enterprise In The United StateseBookNATIONAL ACADEMIES PRESS09-20120,00€
-
Facing The Reality Of Drug-Resistant Tuberculosis In IndiaeBookNATIONAL ACADEMIES PRESS07-20120,00€
-
Facing The Reality Of Drug-Resistant Tuberculosis In IndiaeBookNATIONAL ACADEMIES PRESS07-20120,00€
-
Strengthening A Workforce For Innovative Regulatory Science In Therapeutics DevelopmenteBookNATIONAL ACADEMIES PRESS04-20120,00€
-
Strengthening A Workforce For Innovative Regulatory Science In Therapeutics DevelopmenteBookNATIONAL ACADEMIES PRESS04-20120,00€
-
Public Engagement And Clinical TrialseBookNATIONAL ACADEMIES PRESS02-20120,00€
-
Public Engagement And Clinical TrialseBookNATIONAL ACADEMIES PRESS02-20120,00€
-
Advancing Regulatory Science For Medical Countermeasure DevelopmenteBookNATIONAL ACADEMIES PRESS07-20110,00€
-
Advancing Regulatory Science For Medical Countermeasure DevelopmenteBookNATIONAL ACADEMIES PRESS07-20110,00€
-
New Profile Of Drug-Resistant Tuberculosis In RussiaeBookNATIONAL ACADEMIES PRESS07-20110,00€
-
New Profile Of Drug-Resistant Tuberculosis In RussiaeBookNATIONAL ACADEMIES PRESS07-20110,00€
-
Emerging Threat Of Drug-Resistant Tuberculosis In Southern AfricaeBookNATIONAL ACADEMIES PRESS03-20110,00€
-
Emerging Threat Of Drug-Resistant Tuberculosis In Southern AfricaeBookNATIONAL ACADEMIES PRESS03-20110,00€
-
Building A National Framework For The Establishment Of Regulatory Science For Drug DevelopmenteBookNATIONAL ACADEMIES PRESS02-20110,00€
-
Building A National Framework For The Establishment Of Regulatory Science For Drug DevelopmenteBookNATIONAL ACADEMIES PRESS02-20110,00€
-
Direct-To-Consumer Genetic TestingeBookNATIONAL ACADEMIES PRESS12-20100,00€
-
Direct-To-Consumer Genetic TestingeBookNATIONAL ACADEMIES PRESS12-20100,00€
-
Transforming Clinical Research In The United StateseBookNATIONAL ACADEMIES PRESS10-20100,00€
-
Transforming Clinical Research In The United StateseBookNATIONAL ACADEMIES PRESS10-20100,00€
-
Public Health Emergency Medical Countermeasures EnterpriseeBookNATIONAL ACADEMIES PRESS06-20100,00€
-
Public Health Emergency Medical Countermeasures EnterpriseeBookNATIONAL ACADEMIES PRESS06-20100,00€
-
Accelerating The Development Of Biomarkers For Drug SafetyeBookNATIONAL ACADEMIES PRESS07-20090,00€
-
Accelerating The Development Of Biomarkers For Drug SafetyeBookNATIONAL ACADEMIES PRESS07-20090,00€
-
Breakthrough Business ModelseBookNATIONAL ACADEMIES PRESS02-20090,00€
-
Breakthrough Business ModelseBookNATIONAL ACADEMIES PRESS02-20090,00€
-
Addressing The Barriers To Pediatric Drug DevelopmenteBookNATIONAL ACADEMIES PRESS08-20080,00€
-
Addressing The Barriers To Pediatric Drug DevelopmenteBookNATIONAL ACADEMIES PRESS08-20080,00€
-
Emerging Safety ScienceeBookNATIONAL ACADEMIES PRESS04-20080,00€
-
Emerging Safety ScienceeBookNATIONAL ACADEMIES PRESS04-20080,00€
-
Challenges For The FdaeBookNATIONAL ACADEMIES PRESS10-20070,00€
-
Challenges For The FdaeBookNATIONAL ACADEMIES PRESS10-20070,00€
-
Understanding The Benefits And Risks Of PharmaceuticalseBookNATIONAL ACADEMIES PRESS08-20070,00€
-
Understanding The Benefits And Risks Of PharmaceuticalseBookNATIONAL ACADEMIES PRESS08-20070,00€
-
Adverse Drug Event ReportingeBookNATIONAL ACADEMIES PRESS04-20070,00€
-
Adverse Drug Event ReportingeBookNATIONAL ACADEMIES PRESS04-20070,00€